Fore Genomics
PrivateLast Round
Seed
Jan 28, 2025
Total Funding Raised
$2.1M
Company Overview
Fore Genomics is a biotechnology company that provides comprehensive pediatric genetic health screening services for newborns, infants, and children.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Healthcare Analytics, Medical AI
Business Model
B2C
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Fore Genomics Comparables
Compare Fore Genomics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nurture Genomics | 91% | |
| Fulgent Genetics, Inc. | 83% | |
| GeneDx Holdings Corp. | 78% |
Fore Genomics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jan 28, 2025 | ||||
| Seed | Sep 1, 2018 |
Fore Genomics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MindUP | Seed |
| Israel Innovation Authority | Seed |
| GoodPaper Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 1, 2025
Monthly visitors grew 94% MoM, from 772 to 1.5K.
- May 2, 2025
Monthly visitors increased 1106% MoM, from 64 to 772.
Fore Genomics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Fore Genomics's valuation, stock price, and market status.
Is Fore Genomics a public or private company?
Fore Genomics is a private company.
What is the current stock price of Fore Genomics?
Fore Genomics is a private company with no public stock price. No recent secondary market data is available.
How much is Fore Genomics worth (valuation)?
Valuation information for Fore Genomics is not publicly available.
Can I buy Fore Genomics stock?
Fore Genomics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Fore Genomics's last funding round?
Fore Genomics's most recent funding round was Seed on January 28, 2025.
Who are the main investors in Fore Genomics?
Key investors in Fore Genomics include MindUP, Israel Innovation Authority, GoodPaper Ventures.
Will Fore Genomics IPO soon?
No public IPO plans have been announced for Fore Genomics.
How can I track Fore Genomics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Fore Genomics's secondary market activity and sign up for updates.